Can a patch of your own retina restore clearer vision?
NCT ID NCT07767539
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This trial tests a new surgical technique for people with an epiretinal membrane, a condition where abnormal tissue grows on the retina and blurs or distorts vision. The standard treatment is to peel off this membrane, but the retina may not fully heal. The new approach uses a small piece of the patient's own retinal tissue to cover the area after removal, aiming to promote more natural healing. Participants will be randomly assigned to receive either the new technique or standard surgery, and their vision and retinal structure will be monitored over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A surgical procedure using a patient's own internal limiting membrane (ILM) patch to cover the macula after epiretinal membrane removal.
- What this could lead to
- If successful, this technique could improve visual recovery and restore the retina's normal structure better than standard surgery for epiretinal membrane.
- What could go wrong
- This is a relatively new surgical approach, and its benefits over standard peeling are not yet proven. Risks include surgical complications and the possibility that the patch may not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC EPIRETINAL MEMBRANE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.